Published inStoic VCWhy we invested in Neurode.Stoic VC memo on Neurode’s $3.5M US Pre-seedOct 6Oct 6
Published inStoic VCWhy we doubled down on Kinoxis.Stoic VC memo on Kinoxis Therapeutics Pty Ltd $14.5M Series BSep 1Sep 1
State of venture markets in 2023My key observations on deep tech venture capital this yearDec 24, 2023Dec 24, 2023
Published inStoic VCStoic’s Year in review 20232023 has been another big year at Stoic. We first provide commentary on the venture market this year. We then dig into what we’ve been up…Dec 22, 2023Dec 22, 2023
Published inStoic VCA primer on building Neurotech — part 2A short-form playbook for early stage founders fixing the brain.Dec 12, 2023Dec 12, 2023
Published inStoic VCA primer on building Neurotech — part 1A short-form playbook for early stage founders fixing the brain.Nov 21, 2023Nov 21, 2023
Published inStoic VCOur Investment in LenexaWe’re pleased to be leading Lenexa’s pre-series A, a team bridging geriatric care with the future of preventive medicine.Feb 13, 2023Feb 13, 2023
Published inStoic VCFounders guide to Stoicism.The origin behind our VC fund.Oct 18, 2022Oct 18, 2022
Published inStoic VCOur Investment in BioscoutBioscout are on a mission to put farmers in the driving seat and we‘re excited to be backing the team in their AU $3m seed round alongside…Jun 22, 2022Jun 22, 2022
